Molecular Diagnostics
A Single-Cell RNA-Sequencing-Based Non-Invasive Screening Tool for Endometriosis
Results presented in a recent paper lay the ground work for using menstrual effluent (ME) as an effective screening tool for identifying endometriosis in patients with chronic symptoms suggestive of this disorder. More...21 Sep 2022
Bioperfectus Launches New MPXV Detection Kits for Better Control of Monkeypox Virus Outbreak
Since January 2022, cases of monkeypox have been reported across almost 60,000 in 102 countries and regions. In order to assist in efforts to control the monkeypox outbreak, Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) has launched four new PCR products. More...21 Sep 2022
New Diagnostic Tool Reads Fracture Risk in Drop of Blood
A new device diagnoses bone fragility based on a novel approach via blood sampling. This test is much more specific than current techniques and will significantly improve diagnosis and advance the development of new treatments for osteoporosis. More...21 Sep 2022
Simple Blood and Urine Test Can Help Patients with Chronic Kidney Disease
A simple blood and urine test can identify those most at risk of severe complications of chronic kidney disease. However, many patients and physicians remain unaware of the test’s life-saving potential, according to a new study. More...21 Sep 2022
New Biomarkers to Help Gauge Response of Melanoma Patients to Immune Checkpoint Therapy
Since only a subset of melanoma patients respond to immunotherapy with checkpoint inhibitors, predictive biomarkers are critically needed to guide treatment decisions and develop approaches to the treatment of therapeutic resistance. More...20 Sep 2022
Ultima Genomics Sequencer for Single-Cell RNA-Seq Evaluated
Single-cell RNA sequencing (scRNA-seq) enables the study and characterization of cellular states and pathways at ever-growing investigational scales, including the Human Cell Atlas, cell atlases for tumors and other diseases, and large-scale Perturb-Seq screens of millions of cells under genetic or drug perturbations. More...19 Sep 2022
AI-Enabled POC Device Detects Cancers Without Biopsies
In a study, a unique type of nanoparticle called a “nanorattle” accurately identified head and neck cancers through an AI-enabled point-of-care device that could revolutionize how these cancers and other diseases are detected in low-resource areas to improve global health. More...15 Sep 2022
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Hemodynamic System Monitor
OptoMonitor
Gold Member
Hybrid Pipette
SWITCH
In Other News
Endotrophin Blood Test Can Predict Outcomes in Patients with Heart Failure
Inherited Genetic Variants Increase Risk of Hodgkin Lymphoma
Molecular Endometrial Cancer Test Developed
Portable Sample-to-Answer PCR System Enables Multiplex Real-Time Detection of 27 Targets
Simple Blood Test Can Detect Early-Stage Colorectal Cancer from Gut Bacteria
Simple Blood Test Quickly and Accurately Detects Ovarian Cancer
Blood-Based Liver Disease Test Could Replace Invasive Biopsy
MCED Tests Mark New Era of Early Cancer Detection
Metabolic Disturbances Characterize Patients with Idiopathic Intracranial Hypertension
Multiparameter Test Could Detect and Diagnose Cancer from a Milliliter of Blood
Portable, Sample to Answer PCR Device Delivers Accurate Results in 30 Minutes at Point of Need
Rapid POC Diagnostic Test for Syphilis Could Produce Results in Under 20 Minutes
African-Specific Molecular Taxonomy of Prostate Cancer Revealed
Elevated Blood Levels of Neurofilament Light Chain Predict Likelihood of Neurotoxicity Following CAR-T Immunotherapy
qPCR Assay Identifies Melanoma Patients With Low-Risk Tumor That Could Avoid Invasive Biopsy
Improved ALS Blood Test Requires Less Stringent Storage and Work Conditions
AI Algorithm Combined With Blood Test Quickly and Accurately Diagnoses Heart Attacks in Women
EV-based Liquid Biopsy for the Diagnosis of Early-Stage Liver Cancer
Fast, Accurate and Portable Molecular Analyzer to Revolutionize Diagnostics
First-of-Its-Kind Blood Test Evaluates Severity and Predicts Survivability in Rare Lung Disease
New Sensitive Blood Test Detects, Characterizes and Monitors Small Cell Lung Cancer
Roche Launches Next-Generation Digital PCR System
World-First Preventative DNA Screening for Cancer and Heart Disease Risk
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
